Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Language Processing | 18 | 2024 | 1041 | 3.430 |
Why?
|
Advance Care Planning | 11 | 2024 | 662 | 2.390 |
Why?
|
Palliative Care | 28 | 2024 | 3493 | 2.310 |
Why?
|
Cardiac Resynchronization Therapy | 5 | 2022 | 531 | 2.220 |
Why?
|
Terminal Care | 13 | 2022 | 1694 | 2.140 |
Why?
|
Documentation | 12 | 2024 | 871 | 1.770 |
Why?
|
Intensive Care Units | 8 | 2021 | 3679 | 1.580 |
Why?
|
Electronic Health Records | 18 | 2024 | 4468 | 1.030 |
Why?
|
Artificial Intelligence | 3 | 2023 | 2214 | 0.960 |
Why?
|
LDL-Receptor Related Proteins | 6 | 2011 | 115 | 0.950 |
Why?
|
Respiration, Artificial | 5 | 2021 | 2569 | 0.890 |
Why?
|
Pneumoperitoneum | 2 | 2021 | 46 | 0.850 |
Why?
|
Neoplasms | 22 | 2024 | 21683 | 0.810 |
Why?
|
Meningeal Neoplasms | 2 | 2019 | 1241 | 0.710 |
Why?
|
Mammary Glands, Animal | 4 | 2009 | 276 | 0.700 |
Why?
|
Admitting Department, Hospital | 1 | 2018 | 5 | 0.680 |
Why?
|
Patient Preference | 3 | 2019 | 890 | 0.610 |
Why?
|
Critical Care | 3 | 2021 | 2647 | 0.610 |
Why?
|
Defibrillators, Implantable | 2 | 2017 | 1440 | 0.580 |
Why?
|
Informed Consent | 2 | 2022 | 995 | 0.560 |
Why?
|
Prejudice | 1 | 2020 | 570 | 0.550 |
Why?
|
Wnt Proteins | 4 | 2009 | 721 | 0.550 |
Why?
|
Hospital Mortality | 6 | 2021 | 5317 | 0.540 |
Why?
|
Heart Failure | 5 | 2022 | 10900 | 0.540 |
Why?
|
Withholding Treatment | 1 | 2019 | 599 | 0.510 |
Why?
|
Point-of-Care Systems | 1 | 2023 | 1177 | 0.490 |
Why?
|
Language | 1 | 2024 | 1471 | 0.490 |
Why?
|
Information Dissemination | 1 | 2022 | 1099 | 0.470 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 642 | 0.460 |
Why?
|
Hospice Care | 4 | 2022 | 672 | 0.440 |
Why?
|
Health Status Indicators | 1 | 2018 | 969 | 0.440 |
Why?
|
Allied Health Personnel | 1 | 2014 | 162 | 0.430 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1405 | 0.410 |
Why?
|
Leukemia, Myeloid | 3 | 2004 | 707 | 0.400 |
Why?
|
Humans | 92 | 2024 | 744343 | 0.400 |
Why?
|
Telomerase | 6 | 2012 | 730 | 0.380 |
Why?
|
Neurosurgical Procedures | 1 | 2022 | 2002 | 0.370 |
Why?
|
Hospitals | 3 | 2023 | 3952 | 0.370 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2010 | 61 | 0.370 |
Why?
|
Breast Neoplasms | 5 | 2022 | 20822 | 0.370 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2010 | 188 | 0.350 |
Why?
|
Aged | 35 | 2023 | 163280 | 0.350 |
Why?
|
Salivary Glands | 1 | 2010 | 229 | 0.340 |
Why?
|
Mammary Neoplasms, Animal | 2 | 2007 | 137 | 0.330 |
Why?
|
Substance-Related Disorders | 2 | 2022 | 4258 | 0.320 |
Why?
|
Heart-Assist Devices | 1 | 2018 | 1194 | 0.320 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4851 | 0.310 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5319 | 0.300 |
Why?
|
Patient Selection | 1 | 2019 | 4215 | 0.300 |
Why?
|
Perception | 1 | 2014 | 1198 | 0.300 |
Why?
|
Karyotyping | 5 | 2004 | 1243 | 0.290 |
Why?
|
Wnt1 Protein | 1 | 2006 | 118 | 0.280 |
Why?
|
Algorithms | 4 | 2021 | 13881 | 0.280 |
Why?
|
Mammary Glands, Human | 1 | 2007 | 199 | 0.270 |
Why?
|
Female | 41 | 2023 | 380194 | 0.270 |
Why?
|
Telemedicine | 1 | 2023 | 2872 | 0.270 |
Why?
|
Male | 35 | 2023 | 350118 | 0.260 |
Why?
|
Quality of Life | 6 | 2022 | 12804 | 0.260 |
Why?
|
Hospitalization | 5 | 2023 | 10262 | 0.260 |
Why?
|
Aged, 80 and over | 14 | 2022 | 57776 | 0.260 |
Why?
|
Models, Biological | 2 | 2021 | 9583 | 0.260 |
Why?
|
Health Personnel | 1 | 2018 | 3218 | 0.250 |
Why?
|
Mental Disorders | 2 | 2022 | 6600 | 0.250 |
Why?
|
PTEN Phosphohydrolase | 1 | 2010 | 1142 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2010 | 2109 | 0.240 |
Why?
|
Veterans Health | 2 | 2023 | 216 | 0.240 |
Why?
|
Death | 4 | 2021 | 678 | 0.230 |
Why?
|
Neoplastic Stem Cells | 2 | 2012 | 1376 | 0.230 |
Why?
|
Quality Improvement | 5 | 2024 | 3749 | 0.230 |
Why?
|
Fatigue | 2 | 2022 | 1531 | 0.220 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3674 | 0.220 |
Why?
|
Advance Directives | 1 | 2024 | 246 | 0.210 |
Why?
|
Retrospective Studies | 16 | 2023 | 77449 | 0.210 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2020 | 980 | 0.200 |
Why?
|
Referral and Consultation | 1 | 2014 | 3528 | 0.190 |
Why?
|
Cytogenetic Analysis | 1 | 2001 | 295 | 0.190 |
Why?
|
Videoconferencing | 1 | 2023 | 195 | 0.190 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2004 | 651 | 0.190 |
Why?
|
Disabled Persons | 2 | 2020 | 1212 | 0.190 |
Why?
|
Videotape Recording | 1 | 2022 | 352 | 0.180 |
Why?
|
Patient Education as Topic | 3 | 2022 | 2278 | 0.180 |
Why?
|
Middle Aged | 20 | 2021 | 213383 | 0.180 |
Why?
|
Epidermal Growth Factor | 1 | 2003 | 708 | 0.180 |
Why?
|
Wheelchairs | 1 | 2020 | 77 | 0.180 |
Why?
|
Communication | 6 | 2023 | 3749 | 0.180 |
Why?
|
Patient Care Planning | 3 | 2020 | 921 | 0.180 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3843 | 0.180 |
Why?
|
Computers | 1 | 2022 | 612 | 0.170 |
Why?
|
New York | 1 | 2022 | 886 | 0.170 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 3923 | 0.170 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2012 | 2942 | 0.170 |
Why?
|
Cohort Studies | 5 | 2022 | 40561 | 0.170 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 25043 | 0.170 |
Why?
|
Research Personnel | 1 | 2024 | 573 | 0.170 |
Why?
|
Research Report | 1 | 2022 | 355 | 0.160 |
Why?
|
Quality Indicators, Health Care | 4 | 2021 | 1831 | 0.160 |
Why?
|
Pandemics | 4 | 2023 | 8388 | 0.160 |
Why?
|
Trust | 1 | 2022 | 505 | 0.160 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3617 | 0.150 |
Why?
|
Temperature | 1 | 2024 | 2206 | 0.150 |
Why?
|
Health Communication | 1 | 2020 | 214 | 0.150 |
Why?
|
Ethics, Medical | 1 | 2022 | 792 | 0.150 |
Why?
|
Surgical Procedures, Operative | 2 | 2019 | 1876 | 0.140 |
Why?
|
Adult | 18 | 2022 | 214055 | 0.140 |
Why?
|
Colorectal Neoplasms | 3 | 2021 | 6773 | 0.140 |
Why?
|
Signal Transduction | 9 | 2012 | 23403 | 0.140 |
Why?
|
Resuscitation Orders | 1 | 2018 | 269 | 0.140 |
Why?
|
Data Mining | 1 | 2021 | 537 | 0.140 |
Why?
|
Educational Status | 1 | 2024 | 2540 | 0.140 |
Why?
|
Young Adult | 6 | 2020 | 56430 | 0.130 |
Why?
|
Prognosis | 4 | 2021 | 29063 | 0.130 |
Why?
|
Gastrostomy | 1 | 2018 | 309 | 0.130 |
Why?
|
Myelodysplastic Syndromes | 2 | 2003 | 1352 | 0.130 |
Why?
|
Spirituality | 1 | 2019 | 405 | 0.130 |
Why?
|
United States | 7 | 2020 | 69872 | 0.130 |
Why?
|
Nausea | 1 | 2018 | 673 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2009 | 9438 | 0.120 |
Why?
|
Pilot Projects | 3 | 2023 | 8324 | 0.120 |
Why?
|
Qualitative Research | 4 | 2024 | 2682 | 0.120 |
Why?
|
Health Services Needs and Demand | 1 | 2022 | 1411 | 0.120 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2018 | 624 | 0.120 |
Why?
|
Boston | 4 | 2020 | 9313 | 0.110 |
Why?
|
Chronic Disease | 2 | 2018 | 9146 | 0.110 |
Why?
|
Fatty Liver | 1 | 2019 | 727 | 0.110 |
Why?
|
Bayes Theorem | 1 | 2021 | 2309 | 0.110 |
Why?
|
Transcription, Genetic | 3 | 2012 | 7722 | 0.110 |
Why?
|
Quality of Health Care | 4 | 2023 | 4371 | 0.110 |
Why?
|
Fibroblasts | 1 | 2003 | 4161 | 0.110 |
Why?
|
Needs Assessment | 1 | 2018 | 1147 | 0.110 |
Why?
|
Research | 1 | 2021 | 1999 | 0.100 |
Why?
|
Sex Distribution | 1 | 2017 | 2297 | 0.100 |
Why?
|
Translocation, Genetic | 3 | 2003 | 1420 | 0.100 |
Why?
|
Depression | 2 | 2023 | 7766 | 0.100 |
Why?
|
Education | 1 | 2015 | 543 | 0.100 |
Why?
|
ROC Curve | 1 | 2019 | 3527 | 0.100 |
Why?
|
Nucleic Acid Hybridization | 2 | 2004 | 1375 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 1 | 2020 | 1164 | 0.100 |
Why?
|
Delirium | 1 | 2023 | 1609 | 0.100 |
Why?
|
Caregivers | 4 | 2024 | 2094 | 0.100 |
Why?
|
Hospital Administration | 1 | 2015 | 353 | 0.100 |
Why?
|
Age Distribution | 1 | 2017 | 2902 | 0.100 |
Why?
|
Decision Making | 3 | 2019 | 3887 | 0.100 |
Why?
|
Patient Participation | 1 | 2020 | 1457 | 0.100 |
Why?
|
Acetyltransferases | 2 | 2003 | 234 | 0.090 |
Why?
|
Paclitaxel | 1 | 2018 | 1708 | 0.090 |
Why?
|
DNA, Complementary | 2 | 2004 | 2050 | 0.090 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2003 | 354 | 0.090 |
Why?
|
Adolescent | 5 | 2019 | 85781 | 0.090 |
Why?
|
Survival Analysis | 2 | 2021 | 10252 | 0.090 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2003 | 460 | 0.090 |
Why?
|
Mice, 129 Strain | 1 | 2010 | 386 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 840 | 0.090 |
Why?
|
Health Surveys | 1 | 2019 | 4037 | 0.090 |
Why?
|
Bariatric Surgery | 1 | 2019 | 952 | 0.080 |
Why?
|
Flow Cytometry | 2 | 2010 | 5974 | 0.080 |
Why?
|
Critical Illness | 2 | 2020 | 2670 | 0.080 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2010 | 692 | 0.080 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2011 | 199 | 0.080 |
Why?
|
Gene Amplification | 3 | 2003 | 1063 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2019 | 1863 | 0.080 |
Why?
|
Time Factors | 2 | 2021 | 40075 | 0.080 |
Why?
|
Up-Regulation | 3 | 2008 | 4217 | 0.080 |
Why?
|
Physician-Patient Relations | 2 | 2019 | 3229 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2208 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15076 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2012 | 713 | 0.080 |
Why?
|
Goals | 2 | 2023 | 706 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2018 | 2266 | 0.070 |
Why?
|
Patient Compliance | 1 | 2018 | 2684 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3589 | 0.070 |
Why?
|
Chromosome Banding | 2 | 2004 | 278 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2006 | 3920 | 0.070 |
Why?
|
Cyclic AMP | 1 | 2011 | 1472 | 0.070 |
Why?
|
Salivary Gland Neoplasms | 1 | 2010 | 298 | 0.070 |
Why?
|
Gene Deletion | 2 | 2006 | 2751 | 0.070 |
Why?
|
Pain | 2 | 2021 | 4986 | 0.070 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2007 | 258 | 0.070 |
Why?
|
Odds Ratio | 1 | 2019 | 9849 | 0.070 |
Why?
|
Models, Statistical | 1 | 2021 | 5102 | 0.070 |
Why?
|
beta Catenin | 2 | 2012 | 1059 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2759 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3158 | 0.070 |
Why?
|
Sirolimus | 2 | 2010 | 1564 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7785 | 0.070 |
Why?
|
Cluster Analysis | 2 | 2020 | 2715 | 0.070 |
Why?
|
DNA-Binding Proteins | 7 | 2005 | 9648 | 0.060 |
Why?
|
Spectral Karyotyping | 1 | 2004 | 12 | 0.060 |
Why?
|
Inpatients | 1 | 2016 | 2518 | 0.060 |
Why?
|
Gene Targeting | 1 | 2008 | 880 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5442 | 0.060 |
Why?
|
Tumor Burden | 1 | 2010 | 1915 | 0.060 |
Why?
|
Chromosome Breakage | 2 | 2003 | 173 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2012 | 2019 | 0.060 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2006 | 430 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7279 | 0.060 |
Why?
|
Acute Disease | 3 | 2004 | 7149 | 0.060 |
Why?
|
Viral Matrix Proteins | 1 | 2005 | 186 | 0.060 |
Why?
|
Cri-du-Chat Syndrome | 1 | 2003 | 13 | 0.060 |
Why?
|
Trans-Activators | 3 | 2003 | 2924 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2011 | 1222 | 0.060 |
Why?
|
Mice | 9 | 2012 | 81183 | 0.060 |
Why?
|
Cell Separation | 1 | 2009 | 1751 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14722 | 0.060 |
Why?
|
Liver | 1 | 2019 | 7474 | 0.060 |
Why?
|
Protein Kinases | 2 | 2007 | 1640 | 0.060 |
Why?
|
Receptors, Virus | 1 | 2006 | 648 | 0.060 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 686 | 0.050 |
Why?
|
Osteoblasts | 1 | 2008 | 1166 | 0.050 |
Why?
|
Proto-Oncogenes | 1 | 2003 | 321 | 0.050 |
Why?
|
Haplotypes | 1 | 2009 | 2779 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8037 | 0.050 |
Why?
|
Interferon-alpha | 1 | 2006 | 895 | 0.050 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2003 | 417 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2019 | 7659 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5256 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18370 | 0.050 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2002 | 84 | 0.050 |
Why?
|
Medicare | 1 | 2019 | 6566 | 0.050 |
Why?
|
Animals | 10 | 2012 | 168757 | 0.050 |
Why?
|
Epithelial Cells | 3 | 2009 | 3690 | 0.050 |
Why?
|
Herpesvirus 4, Human | 1 | 2005 | 1041 | 0.040 |
Why?
|
Focus Groups | 1 | 2024 | 1321 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2010 | 14557 | 0.040 |
Why?
|
Cell Division | 2 | 2003 | 4568 | 0.040 |
Why?
|
Apoptosis | 3 | 2010 | 9727 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2948 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2004 | 1813 | 0.040 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2002 | 570 | 0.040 |
Why?
|
Mentors | 1 | 2022 | 631 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1677 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2008 | 3462 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11366 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2003 | 3701 | 0.040 |
Why?
|
Telomere | 1 | 2003 | 910 | 0.040 |
Why?
|
Base Sequence | 5 | 2011 | 12797 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2006 | 2938 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9734 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2003 | 5853 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2003 | 3523 | 0.030 |
Why?
|
Mobility Limitation | 1 | 2020 | 409 | 0.030 |
Why?
|
Stem Cells | 1 | 2009 | 3567 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2006 | 2849 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15295 | 0.030 |
Why?
|
Patients | 1 | 2022 | 900 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 9959 | 0.030 |
Why?
|
Medical Audit | 1 | 2016 | 467 | 0.030 |
Why?
|
Lymphoma, B-Cell | 1 | 2002 | 931 | 0.030 |
Why?
|
Risk Factors | 2 | 2019 | 72290 | 0.030 |
Why?
|
Social Responsibility | 1 | 2017 | 389 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2003 | 1581 | 0.030 |
Why?
|
Cell Line, Tumor | 5 | 2012 | 16689 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 2011 | 18111 | 0.030 |
Why?
|
Carcinoma | 2 | 2005 | 2375 | 0.030 |
Why?
|
Bone Marrow | 1 | 2004 | 2948 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2005 | 13033 | 0.030 |
Why?
|
DNA Repair | 1 | 2003 | 2046 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2008 | 11483 | 0.030 |
Why?
|
Data Collection | 1 | 2022 | 3341 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 2 | 2003 | 4554 | 0.030 |
Why?
|
Prevalence | 2 | 2020 | 15226 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4751 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2022 | 1786 | 0.030 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2002 | 1378 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 3703 | 0.030 |
Why?
|
Vimentin | 1 | 2012 | 261 | 0.030 |
Why?
|
Program Evaluation | 1 | 2020 | 2488 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2000 | 3772 | 0.020 |
Why?
|
CREB-Binding Protein | 2 | 2003 | 151 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 21827 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2006 | 12072 | 0.020 |
Why?
|
Catalysis | 1 | 2012 | 761 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2006 | 10481 | 0.020 |
Why?
|
Transcription Factors | 3 | 2012 | 12208 | 0.020 |
Why?
|
Tumor Cells, Cultured | 3 | 2005 | 6314 | 0.020 |
Why?
|
RNA | 1 | 2000 | 2749 | 0.020 |
Why?
|
Second Messenger Systems | 1 | 2011 | 206 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2002 | 2020 | 0.020 |
Why?
|
Histone Acetyltransferases | 2 | 2003 | 336 | 0.020 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 2011 | 307 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2006 | 7880 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3022 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 491 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2012 | 644 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5867 | 0.020 |
Why?
|
Obesity, Morbid | 1 | 2019 | 1213 | 0.020 |
Why?
|
Phosphorylation | 2 | 2011 | 8436 | 0.020 |
Why?
|
Primary Health Care | 1 | 2023 | 4558 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6756 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 13989 | 0.020 |
Why?
|
Gene Expression | 2 | 2012 | 7799 | 0.020 |
Why?
|
Chromones | 1 | 2006 | 154 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3086 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 1988 | 0.020 |
Why?
|
Consensus Sequence | 1 | 2006 | 377 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1655 | 0.020 |
Why?
|
STAT Transcription Factors | 1 | 2006 | 182 | 0.020 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2006 | 175 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2003 | 2649 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12788 | 0.020 |
Why?
|
Length of Stay | 1 | 2018 | 6309 | 0.020 |
Why?
|
Luciferases | 1 | 2006 | 733 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2012 | 8428 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2011 | 13815 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3616 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5987 | 0.020 |
Why?
|
Ligands | 1 | 2011 | 3282 | 0.010 |
Why?
|
RNA Nucleotidyltransferases | 1 | 2003 | 64 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2889 | 0.010 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2006 | 520 | 0.010 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2003 | 67 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2012 | 2969 | 0.010 |
Why?
|
Morpholines | 1 | 2006 | 571 | 0.010 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2003 | 105 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1783 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2012 | 1333 | 0.010 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2006 | 611 | 0.010 |
Why?
|
Cell Line | 2 | 2011 | 15997 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2006 | 1547 | 0.010 |
Why?
|
Child, Preschool | 2 | 2003 | 41006 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2003 | 318 | 0.010 |
Why?
|
Virus Latency | 1 | 2005 | 358 | 0.010 |
Why?
|
Binding Sites | 1 | 2011 | 6114 | 0.010 |
Why?
|
Curriculum | 1 | 2015 | 3605 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3505 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2002 | 193 | 0.010 |
Why?
|
Paraffin Embedding | 1 | 2002 | 299 | 0.010 |
Why?
|
Cell Membrane | 1 | 2011 | 3748 | 0.010 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2003 | 294 | 0.010 |
Why?
|
Trisomy | 1 | 2002 | 266 | 0.010 |
Why?
|
DEAD-box RNA Helicases | 1 | 2003 | 375 | 0.010 |
Why?
|
Cell Lineage | 1 | 2009 | 2504 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9386 | 0.010 |
Why?
|
Cell Cycle | 1 | 2008 | 2967 | 0.010 |
Why?
|
Introns | 1 | 2003 | 991 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 2002 | 915 | 0.010 |
Why?
|
Tumor Virus Infections | 1 | 2002 | 452 | 0.010 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2003 | 670 | 0.010 |
Why?
|
Chromosomes | 1 | 2002 | 596 | 0.010 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2002 | 387 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 53288 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2000 | 698 | 0.010 |
Why?
|
Transfection | 1 | 2006 | 5892 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 2003 | 1179 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|
Gene Dosage | 1 | 2002 | 1252 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 3002 | 0.010 |
Why?
|
Exons | 1 | 2003 | 2437 | 0.010 |
Why?
|
Mice, SCID | 1 | 2002 | 2716 | 0.010 |
Why?
|
Papillomaviridae | 1 | 2002 | 1119 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3798 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2002 | 1836 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 63114 | 0.010 |
Why?
|
Rats | 1 | 2011 | 24260 | 0.010 |
Why?
|
Computational Biology | 1 | 2006 | 3521 | 0.010 |
Why?
|
DNA Damage | 1 | 2003 | 2432 | 0.010 |
Why?
|
Lymphocytes | 1 | 2000 | 2617 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2005 | 2245 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2002 | 4328 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2002 | 1587 | 0.010 |
Why?
|
Mutation | 2 | 2006 | 29786 | 0.010 |
Why?
|
Infant | 1 | 2003 | 35136 | 0.000 |
Why?
|
Child | 1 | 2003 | 77709 | 0.000 |
Why?
|